Maria Nordwall1, Lars Hyllienmark, Johnny Ludvigsson. 1. Division of Paediatrics and Diabetes Research Centre, Department of Molecular and Clinical Medicine, University Hospital, Linköping, Sweden. Maria.Nordvall@lio.se
Abstract
AIM: To describe the prevalence of early complications in an unselected population of patients with type 1 diabetes mellitus (DM1) diagnosed in childhood with intensive insulin treatment from diagnosis. METHODS: Eighty children and adolescents with DM1, age 7-22 years and DM1 duration >3 years, were studied. Neuropathy was defined as abnormal nerve conduction finding in > or = 2 of 4 nerves (sural and peroneal nerves), nephropathy as albumin excretion rate > or = 20 microg/min and retinopathy as all grades of retinal changes in fundus photographs. RESULTS: The prevalence of neuropathy was 59%, of retinopathy 27% and of nephropathy 5% after 13 years DM1 duration. Mean (SD) long-term HbA1c was 8.4 (0.9)% (DCCT-corrected value). CONCLUSION: Even in a population with intensive insulin treatment from the beginning and fairly good metabolic control, the prevalence of subclinical neuropathy was high, while other diabetic complications were lower than usually reported.
AIM: To describe the prevalence of early complications in an unselected population of patients with type 1 diabetes mellitus (DM1) diagnosed in childhood with intensive insulin treatment from diagnosis. METHODS: Eighty children and adolescents with DM1, age 7-22 years and DM1 duration >3 years, were studied. Neuropathy was defined as abnormal nerve conduction finding in > or = 2 of 4 nerves (sural and peroneal nerves), nephropathy as albumin excretion rate > or = 20 microg/min and retinopathy as all grades of retinal changes in fundus photographs. RESULTS: The prevalence of neuropathy was 59%, of retinopathy 27% and of nephropathy 5% after 13 years DM1 duration. Mean (SD) long-term HbA1c was 8.4 (0.9)% (DCCT-corrected value). CONCLUSION: Even in a population with intensive insulin treatment from the beginning and fairly good metabolic control, the prevalence of subclinical neuropathy was high, while other diabetic complications were lower than usually reported.
Authors: Katherine A Sauder; Jeanette M Stafford; Elizabeth J Mayer-Davis; Elizabeth T Jensen; Sharon Saydah; Amy Mottl; Lawrence M Dolan; Richard F Hamman; Jean M Lawrence; Catherine Pihoker; Santica Marcovina; Ralph B D'Agostino; Dana Dabelea Journal: Lancet Child Adolesc Health Date: 2018-11-06
Authors: Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden Journal: Cardiovasc Diabetol Date: 2016-04-07 Impact factor: 9.951
Authors: Mamta Jaiswal; Jasmin Divers; Dana Dabelea; Scott Isom; Ronny A Bell; Catherine L Martin; David J Pettitt; Sharon Saydah; Catherine Pihoker; Debra A Standiford; Lawrence M Dolan; Santica Marcovina; Barbara Linder; Angela D Liese; Rodica Pop-Busui; Eva L Feldman Journal: Diabetes Care Date: 2017-07-03 Impact factor: 17.152